DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 208 filers reported holding DEPOMED INC in Q4 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $410,000 | +412.5% | 61,464 | +409.4% | 0.00% | – |
| Q1 2018 | $80,000 | -75.6% | 12,067 | -70.2% | 0.00% | -100.0% |
| Q4 2017 | $328,000 | -6.8% | 40,556 | -32.9% | 0.00% | 0.0% |
| Q3 2017 | $352,000 | +10.3% | 60,403 | +102.7% | 0.00% | -50.0% |
| Q2 2017 | $319,000 | -12.8% | 29,794 | +1.4% | 0.00% | 0.0% |
| Q1 2017 | $366,000 | +72.6% | 29,394 | +151.1% | 0.00% | +100.0% |
| Q4 2016 | $212,000 | -72.7% | 11,708 | -62.5% | 0.00% | -80.0% |
| Q3 2016 | $776,000 | -10.4% | 31,200 | -29.1% | 0.01% | -16.7% |
| Q2 2016 | $866,000 | +2693.5% | 44,000 | +1900.0% | 0.01% | – |
| Q1 2016 | $31,000 | -92.4% | 2,200 | -90.2% | 0.00% | -100.0% |
| Q4 2015 | $409,000 | -58.9% | 22,563 | -57.2% | 0.00% | -55.6% |
| Q3 2015 | $995,000 | +175.6% | 52,734 | +213.9% | 0.01% | +125.0% |
| Q2 2015 | $361,000 | +147.3% | 16,800 | +160.0% | 0.00% | +300.0% |
| Q1 2015 | $146,000 | +224.4% | 6,461 | +133.6% | 0.00% | – |
| Q4 2014 | $45,000 | – | 2,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,159,164 | $32,798,000 | 7.35% |
| Senvest Management, LLC | 4,515,935 | $68,597,000 | 6.42% |
| Broadfin Capital, LLC | 2,313,702 | $35,145,000 | 3.68% |
| HAYS ADVISORY LLC | 512,820 | $7,790,000 | 1.03% |
| Ghost Tree Capital, LLC | 120,000 | $1,823,000 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,096 | $9,829,000 | 0.94% |
| TURNER INVESTMENTS LLC | 817,177 | $12,413,000 | 0.74% |
| EMERALD ADVISERS, LLC | 681,346 | $10,350,000 | 0.62% |
| TSP Capital Management Group, LLC | 86,300 | $1,311,000 | 0.60% |
| PERKINS CAPITAL MANAGEMENT INC | 38,500 | $585,000 | 0.49% |